Chair:
Elena Guerini Rocco
European Institute of Oncology, IRCCS,
University of Milan,
Milan, Italy
Speaker:
Marta Casarrubios
Puerta de Hierro Hospital,
Madrid, Spain
Pre-treatment tissue TCR repertoire evenness is associated with complete pathological response in patients with NSCLC receiving neoadjuvant chemoimmunotherapy.
Speaker:
Dr Matteo Allegretti
IRCSS Regina Elena National Cancer Institute,
Rome, Italy
Longitudinal monitoring by liquid biopsy identifies molecular predictors of resistance in advanced HER2‑positive breast cancer.
